Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Business of developing curative therapeutics for patients using the Company’s proprietary52.3M100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States52.3M100.00%